These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of growth factor responsiveness of murine mammary carcinoma cells by cell matrix interactions: correlation of cell proliferation and spreading. Elliott B; Ostman A; Westermark B; Rubin K J Cell Physiol; 1992 Aug; 152(2):292-301. PubMed ID: 1322415 [TBL] [Abstract][Full Text] [Related]
3. Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells. Humes HD; Beals TF; Cieslinski DA; Sanchez IO; Page TP Lab Invest; 1991 Apr; 64(4):538-45. PubMed ID: 2016859 [TBL] [Abstract][Full Text] [Related]
4. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression. Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687 [TBL] [Abstract][Full Text] [Related]
5. Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma. Blanckaert VD; Schelling ME; Elstad CA; Meadows GG Cancer Res; 1993 Sep; 53(17):4075-81. PubMed ID: 8358737 [TBL] [Abstract][Full Text] [Related]
6. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta. Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634 [TBL] [Abstract][Full Text] [Related]
7. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines. Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235 [TBL] [Abstract][Full Text] [Related]
8. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones. Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201 [TBL] [Abstract][Full Text] [Related]
9. CDGF (chicken embryo fibroblast-derived growth factor) is mitogenically related to TGF-beta and modulates PDGF, bFGF, and IGF-I action on sparse NIH/3T3 cells. Geistlich A; Gehring H Exp Cell Res; 1993 Feb; 204(2):329-35. PubMed ID: 8440329 [TBL] [Abstract][Full Text] [Related]
10. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis. Kominsky SL; Doucet M; Brady K; Weber KL J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells. Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499 [TBL] [Abstract][Full Text] [Related]
12. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. Sierra A; Price JE; García-Ramirez M; Méndez O; López L; Fabra A Lab Invest; 1997 Oct; 77(4):357-68. PubMed ID: 9354770 [TBL] [Abstract][Full Text] [Related]
13. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. Krasagakis K; Garbe C; Schrier PI; Orfanos CE Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682 [TBL] [Abstract][Full Text] [Related]
14. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1. Williams AC; Browne SJ; Manning AM; Daffada P; Collard TJ; Paraskeva C Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496 [TBL] [Abstract][Full Text] [Related]
16. Production of transforming growth factors by human colon cancer lines. Coffey RJ; Shipley GD; Moses HL Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610 [TBL] [Abstract][Full Text] [Related]
17. Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts. Schwarz LC; Gingras MC; Goldberg G; Greenberg AH; Wright JA Cancer Res; 1988 Dec; 48(24 Pt 1):6999-7003. PubMed ID: 3056609 [TBL] [Abstract][Full Text] [Related]
18. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro. Sehgal I; Baley PA; Thompson TC Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134 [TBL] [Abstract][Full Text] [Related]